Long-Term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis (KIDNEY WEEK 2023) - Oct 15, 2023 - Abstract #SA-PO876; Pres time: Nov 4, 2023; 10:00 AM - 12:00 PM; Location: Exhibit Hall, Pennsylvania Convention Center; "Voclosporin in conjunction with low-dose glucocorticoids and mycophenolate mofetil (MMF) has shown significant benefit across ancestries and classes of LN. Black patients treated with a voclosporin-based regimen achieved higher rates of renal response than patients treated with MMF and glucocorticoids alone. For patients entering the continuation study, the response was largely durable for up to 3 years."
Clinical • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Gabriel Contreras1; Matthew G. Baker2; Lucy S. Hodge2; Ernie Yap2
|